Literature DB >> 23558627

Metabolic reprogramming in polycystic kidney disease.

Carmen Priolo, Elizabeth P Henske.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23558627     DOI： 10.1038/nm.3140

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  13 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

3.  Autosomal dominant polycystic kidney disease: neoplasia in disguise?

Authors:  P C Harris; M L Watson
Journal:  Nephrol Dial Transplant       Date:  1997-06       Impact factor: 5.992

4.  Tumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependent.

Authors:  Andrey Parkhitko; Faina Myachina; Tasha A Morrison; Khadijah M Hindi; Neil Auricchio; Magdalena Karbowniczek; J Julia Wu; Toren Finkel; David J Kwiatkowski; Jane J Yu; Elizabeth Petri Henske
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-11       Impact factor: 11.205

Review 5.  Apico-basal polarity in polycystic kidney disease epithelia.

Authors:  Patricia D Wilson
Journal:  Biochim Biophys Acta       Date:  2011-06-01

Review 6.  Targeting cancer metabolism: a therapeutic window opens.

Authors:  Matthew G Vander Heiden
Journal:  Nat Rev Drug Discov       Date:  2011-08-31       Impact factor: 84.694

7.  The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I.

Authors:  F Qian; T J Watnick; L F Onuchic; G G Germino
Journal:  Cell       Date:  1996-12-13       Impact factor: 41.582

8.  Proliferative activity of cyst epithelium in human renal cystic diseases.

Authors:  T Nadasdy; Z Laszik; G Lajoie; K E Blick; D E Wheeler; F G Silva
Journal:  J Am Soc Nephrol       Date:  1995-01       Impact factor: 10.121

Review 9.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

10.  Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy.

Authors:  Isaline Rowe; Marco Chiaravalli; Valeria Mannella; Valeria Ulisse; Giacomo Quilici; Monika Pema; Xuewen W Song; Hangxue Xu; Silvia Mari; Feng Qian; York Pei; Giovanna Musco; Alessandra Boletta
Journal:  Nat Med       Date:  2013-03-24       Impact factor: 53.440
View more
  11 in total

1.  Slowing Polycystic Kidney Disease by Fasting.

Authors:  Alessandra Boletta
Journal:  J Am Soc Nephrol       Date:  2015-11-04       Impact factor: 10.121

2.  Disorders of fatty acid oxidation and autosomal recessive polycystic kidney disease-different clinical entities and comparable perinatal renal abnormalities.

Authors:  Agnes Hackl; Katrin Mehler; Ingo Gottschalk; Anne Vierzig; Marcus Eydam; Jan Hauke; Bodo B Beck; Max C Liebau; Regina Ensenauer; Lutz T Weber; Sandra Habbig
Journal:  Pediatr Nephrol       Date:  2017-01-12       Impact factor: 3.714

Review 3.  ADPKD current management and ongoing trials.

Authors:  Francesca Testa; Riccardo Magistroni
Journal:  J Nephrol       Date:  2019-12-18       Impact factor: 3.902

Review 4.  Metabolomics and renal disease.

Authors:  Eugene P Rhee
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-07       Impact factor: 2.894

5.  Metabolic reprogramming in a slowly developing orthologous model of polycystic kidney disease.

Authors:  Katharina Hopp; Emily K Kleczko; Berenice Y Gitomer; Michel Chonchol; Jost Klawitter; Uwe Christians; Jelena Klawitter
Journal:  Am J Physiol Renal Physiol       Date:  2022-01-17

6.  Interleukin-6 mediates PSAT1 expression and serine metabolism in TSC2-deficient cells.

Authors:  Ji Wang; Harilaos Filippakis; Thomas Hougard; Heng Du; Chenyang Ye; Heng-Jia Liu; Long Zhang; Khadijah Hindi; Shefali Bagwe; Julie Nijmeh; John M Asara; Wei Shi; Souheil El-Chemaly; Elizabeth P Henske; Hilaire C Lam
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-28       Impact factor: 11.205

Review 7.  An overview of renal metabolomics.

Authors:  Sahir Kalim; Eugene P Rhee
Journal:  Kidney Int       Date:  2016-09-28       Impact factor: 10.612

8.  Deletion of Pkd1 in renal stromal cells causes defects in the renal stromal compartment and progressive cystogenesis in the kidney.

Authors:  Xuguang Nie; Lois J Arend
Journal:  Lab Invest       Date:  2017-09-11       Impact factor: 5.662

9.  2-Deoxy-d-Glucose Ameliorates PKD Progression.

Authors:  Marco Chiaravalli; Isaline Rowe; Valeria Mannella; Giacomo Quilici; Tamara Canu; Veronica Bianchi; Antonia Gurgone; Sofia Antunes; Patrizia D'Adamo; Antonio Esposito; Giovanna Musco; Alessandra Boletta
Journal:  J Am Soc Nephrol       Date:  2015-11-03       Impact factor: 10.121

10.  Stem cells and fluid flow drive cyst formation in an invertebrate excretory organ.

Authors:  Hanh Thi-Kim Vu; Jochen C Rink; Sean A McKinney; Melainia McClain; Naharajan Lakshmanaperumal; Richard Alexander; Alejandro Sánchez Alvarado
Journal:  Elife       Date:  2015-06-09       Impact factor: 8.140
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.